INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
LJ

Lennon David James

Director, CHIEF EXECUTIVE OFFICERCIK 0001995275

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 6
Max Insider Score35
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Whitehawk Therapeutics, Inc.Director, CHIEF EXECUTIVE OFFICER · Mar 10, 2026
2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A
—
194.0K sh
Sep 15, 2026
Sep 15, 2026
traded Sep 15, 2026
+0d
SEC FORM 4

Evidence

9
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A$200K
51.0K sh
May 14, 2026May 18, 2026
traded May 14, 2026
+4dSEC FORM 4

Evidence

22
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$49K
14.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

32
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$359K
102.4K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC FORM 4

Evidence

32
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$323K
94.1K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

29
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$217K
63.9K sh
Apr 8, 2026Apr 8, 2026
traded Apr 8, 2026
+0dSEC FORM 4

Evidence

5
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
831.1K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

25
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$93K
26.9K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

17
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
775.8K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

5
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
775.8K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

31
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
16.3K sh
Mar 1, 2026Mar 10, 2026
traded Mar 1, 2026
+9dSEC FORM 4

Evidence

27
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
16.3K sh
Mar 1, 2026Mar 10, 2026
traded Mar 1, 2026
+9dSEC FORM 4

Evidence

35
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$17K
5,100 sh
Mar 2, 2026Mar 10, 2026
traded Mar 2, 2026
+8dSEC FORM 4

Evidence